They used the Tumor Immune Estimation Resource (TIMER) online database to analyze the mRNA expression of hepcidin in a number of human cancers, and they discovered increased expressions of hepcidin in colon adenocarcinoma, invasive breast carcinoma, esophageal carcinoma, and other cancer cell types compared to their matched normal tissues. Here, HAMP is linked to cancer.